Australia Stock Exchange release from NOXOPHARM : Appendix 4D and Half Year 2022 Financial Report
21/02/2022 05:08
Australia Stock Exchange release from NOXOPHARM NOX.AX : Appendix 4D and Half Year 2022 Financial Report
Recent news on Noxopharm
See all newsAustralia's Noxopharm hits three-month low on discounted placement
Brief: Noxopharm Receives Commitments For Placement
Brief: Noxopharm Requests Trading Halt Pending Material Capital Raising Announcement
Brief: Noxopharm Announces SOF-SKN Manufacturing Begins To Ensure Clinical Trial Readiness
Australia's Noxopharm rises as novel cancer therapy shows potential